· 12 min read

Medication Safety During Pregnancy & Breastfeeding: What to Ask Your Psychiatrist

Evidence-based guide to psychiatric medication safety during pregnancy & breastfeeding. Learn the risk-benefit framework, specific medication data, and questions to ask your doctor.

psychiatric medication pregnancy breastfeeding medication safety perinatal mental health antidepressants during pregnancy maternal mental health

If you're pregnant or planning to become pregnant while taking psychiatric medication, you're likely facing one of the most difficult medical decisions of your life. Perhaps your OB told you to stop everything immediately. Maybe your family is worried. Or you're lying awake at night, torn between protecting your baby and protecting your own mental health.

You're not alone in this struggle, and the answer isn't as simple as "just stop taking your medication." Understanding psychiatric medication safety during pregnancy and breastfeeding requires looking at the complete picture: the risks of medication exposure, yes, but also the very real risks of untreated mental illness to both you and your baby.

This guide will help you understand the evidence-based framework that perinatal psychiatrists use to make these decisions, and give you the specific questions you need to have an informed, productive conversation with your prescriber.

The Risk-Benefit Framework: Why "Just Stop" Is Often the Wrong Answer

Most conversations about psychiatric medication and pregnancy focus exclusively on fetal exposure risks. But perinatal psychiatrists approach this differently. They weigh medication risks against the documented risks of untreated mental illness during pregnancy.

Those risks are significant. Untreated depression and anxiety during pregnancy are associated with preterm birth, low birth weight, poor prenatal care adherence, and increased risk of postpartum depression. Women who stop antidepressants abruptly often relapse quickly. According to FDA Advisory Committee data, women who discontinued antidepressants near conception had significantly higher recurrent major depressive disorder rates (68%) compared to those who stayed on treatment (26%), with 50% of recurrences happening in the first trimester.

Stopping medication cold turkey without a plan is often the most dangerous option. Your mental health directly affects your ability to care for yourself during pregnancy, attend prenatal appointments, avoid substance use, and bond with your baby after birth.

This doesn't mean medication is always the right choice. It means the decision requires careful consideration of both sides of the equation, ideally with a provider experienced in perinatal psychiatry.

Antidepressants During Pregnancy: What the Evidence Actually Shows

Antidepressants, particularly SSRIs, are the most commonly prescribed psychiatric medications during pregnancy. The good news is that we have substantial safety data, especially for certain medications.

Sertraline (Zoloft) and escitalopram (Lexapro) have the most robust perinatal safety data among SSRIs. They're often considered first-line choices for pregnant women who need antidepressant treatment. Fluoxetine (Prozac) also has extensive data, though its longer half-life can be a consideration.

The ACOG Clinical Practice Guideline No. 5 provides authoritative guidance on assessing safety and efficacy of psychiatric medications during pregnancy and lactation for depression, anxiety, bipolar disorder, and acute psychosis.

Two specific risks deserve clear explanation. Neonatal adaptation syndrome can occur in 10-30% of babies exposed to SSRIs late in pregnancy. Symptoms include jitteriness, irritability, poor feeding, and respiratory issues. These are typically mild and resolve within two weeks. This is not the same as withdrawal or permanent harm.

Persistent pulmonary hypertension of the newborn (PPHN) was associated with SSRI use in some earlier studies, but the absolute risk is very low (about 3 per 1,000 births compared to 1-2 per 1,000 in the general population). More recent research suggests the association may be less clear than initially thought.

SNRIs like venlafaxine and duloxetine have less data than SSRIs but are sometimes necessary for women who haven't responded to other treatments. Bupropion (Wellbutrin) has a reasonable safety profile and is often used, particularly for women concerned about sexual side effects or weight gain.

The old FDA pregnancy category system (A, B, C, D, X) has been replaced with more detailed labeling that describes actual risks and clinical considerations. If your provider mentions "Category C," ask for current, specific data instead.

Breastfeeding and Psychiatric Medications: Finding Current Safety Data

Medications that are relatively safe during pregnancy aren't always safe during breastfeeding, and vice versa. The key is understanding infant exposure levels and having access to current data.

The LactMed database (available free from the National Library of Medicine) is your go-to resource. It provides up-to-date information on medication levels in breast milk and possible effects on nursing infants. Your psychiatrist should be consulting this database when making recommendations.

According to Massachusetts General Hospital's Center for Women's Mental Health, accumulated data indicates that the risk of adverse events in nursing infants from psychiatric medications is low, though many women delay treatment due to concern about medication harm.

Among antidepressants, sertraline, paroxetine, and nortriptyline have the lowest relative infant dose (the amount that reaches the baby through breast milk). The CDC notes that a 2013 AAP clinical report indicates most medications and immunizations are safe while breastfeeding when providers weigh risks and benefits appropriately.

Your provider should calculate the relative infant dose for your specific medication and dose. Generally, levels below 10% are considered acceptable, though this varies by medication class.

One important note from the American Academy of Family Physicians: medications safe in pregnancy are not always safe during breastfeeding. For example, while opioid replacement therapy with methadone or buprenorphine is encouraged during breastfeeding, methadone doses above 100mg daily pose risks of sedation and respiratory depression in infants.

Mood Stabilizers in Pregnancy: Navigating Higher-Risk Medications

This is where the conversation becomes more complex. If you have bipolar disorder and you're stable on a mood stabilizer, the decision to continue or change medication requires careful consideration with a perinatal psychiatrist.

Lamotrigine (Lamictal) is generally the preferred mood stabilizer during pregnancy. It has a reassuring safety profile, though it requires dose adjustments during pregnancy as blood levels drop due to increased metabolism. Your prescriber should monitor levels regularly and may need to increase your dose significantly.

Lithium carries a small increased risk of cardiac malformations, particularly Ebstein's anomaly. Earlier data overestimated this risk; current estimates suggest the absolute risk is low (about 0.6% compared to 0.02% baseline). If you're stable on lithium and become pregnant, don't stop abruptly. The risk of bipolar relapse, particularly manic or mixed episodes, can be severe. Many women continue lithium with careful monitoring, dose adjustments, and fetal echocardiography.

Valproate (Depakote) carries the highest risk among mood stabilizers. It's associated with neural tube defects and cognitive/developmental effects. It should be avoided during pregnancy when possible. If you're on valproate and planning pregnancy, talk to your psychiatrist about transitioning to a safer alternative well before conception.

The key question isn't just "Is this medication safe?" but "What happens if I become unstable?" For someone with bipolar I disorder, the risks of a manic episode during pregnancy (impulsivity, poor judgment, risky behavior, psychosis) may outweigh medication risks.

Anti-Anxiety Medications: Short-Term vs. Long-Term Use

Anxiety during pregnancy is incredibly common, and the approach to medication depends on whether you need acute symptom relief or long-term management.

Benzodiazepines (like lorazepam, clonazepam, or alprazolam) have complex risk profiles. Short-term, occasional use appears relatively safe, though there's some data suggesting possible increased risk of oral clefts with first-trimester exposure. The absolute risk is small. More concerning is chronic use throughout pregnancy, which can lead to neonatal withdrawal symptoms and floppy infant syndrome.

If you're taking benzodiazepines regularly, don't stop suddenly. Benzodiazepine withdrawal can be dangerous. Work with your prescriber on a gradual taper if discontinuation is the goal, or discuss the risks and benefits of continued use at the lowest effective dose.

Buspirone (BuSpar) has limited pregnancy data but is generally considered safer than benzodiazepines for long-term anxiety management. Hydroxyzine (Vistaril) is commonly used for anxiety during pregnancy and has a reassuring safety profile, though it's typically used for short-term or as-needed management rather than daily maintenance.

For many women, SSRIs remain the first-line treatment for anxiety disorders during pregnancy, given their dual benefits for both anxiety and depression and their more extensive safety data.

Antipsychotics in Pregnancy: When Medication Is Non-Negotiable

If you have a condition like schizophrenia, schizoaffective disorder, or bipolar I disorder with psychotic features, antipsychotic medication may be essential for your safety and your baby's wellbeing.

Atypical antipsychotics like olanzapine (Zyprexa), quetiapine (Seroquel), and aripiprazole (Abilify) are commonly used during pregnancy. The main concern is increased risk of gestational diabetes, particularly with olanzapine. Your OB should screen you early and monitor glucose levels carefully.

Typical antipsychotics are sometimes used for severe nausea and vomiting (hyperemesis gravidarum) when other treatments fail. They have longer safety records but come with their own side effect profiles.

If you have a severe mental illness requiring antipsychotic medication, stopping abruptly can lead to psychotic relapse, which poses serious risks including inability to care for yourself, poor prenatal care, and potential harm. The conversation with your psychiatrist should focus on using the lowest effective dose of the medication with the best safety profile for your specific condition.

Just as treatment centers must carefully navigate complex medical billing and documentation requirements to ensure proper care coordination, managing psychiatric medications during pregnancy requires meticulous monitoring and communication between your entire care team.

10 Essential Questions to Ask Your Psychiatrist

Walking into an appointment about medication during pregnancy can feel overwhelming. Here are the specific questions that will help you have a productive, informed conversation:

  • Is my current dose optimized before conception? Sometimes getting stable on the right dose before pregnancy reduces the need for changes later.
  • What are the specific risks of my medication at my dose? Ask for actual numbers, not just "there might be risks."
  • What are the risks if I stop this medication? How quickly do I typically relapse? What does that look like?
  • Can we taper before the first trimester? If you're planning pregnancy, is there time to reduce or discontinue safely?
  • How will you monitor me during pregnancy? What's the follow-up schedule? Will doses need adjustment?
  • Who is my point of contact if symptoms worsen? Can I reach someone quickly if I'm struggling?
  • What's the plan if I relapse? What medication would you restart? At what point?
  • Are you coordinating with my OB? Integrated care is essential. These providers should be talking to each other.
  • What does the breastfeeding evidence say for my specific medication? Ask them to check LactMed with you.
  • What resources do you recommend for more information? Reputable sources can help you feel more confident between appointments.

If your current provider seems uncomfortable with these questions or gives vague answers like "just stop everything to be safe," it may be time to seek a consultation with a perinatal psychiatrist. Your mental health deserves specialized expertise during this critical time.

Building Your Support System: Coordinated Care Matters

The best outcomes happen when your psychiatric care, obstetric care, and support systems work together. Your psychiatrist and OB should be communicating directly about your treatment plan, not leaving you to translate between them.

Consider asking for a joint appointment or conference call if there's disagreement about your medication plan. You deserve providers who respect both your mental health needs and your pregnancy.

Beyond your medical team, connect with other women who've navigated psychiatric medication during pregnancy. Postpartum Support International offers peer support and can help you find local resources. You don't have to make these decisions in isolation.

The infrastructure supporting maternal mental health continues to evolve. Much like how addiction treatment centers must meet rigorous licensing standards to ensure quality care, perinatal mental health services require specialized training and coordination to serve women effectively during this vulnerable time.

Your Mental Health Matters: Making the Decision That's Right for You

There's no universal right answer about psychiatric medication during pregnancy and breastfeeding. The right decision for you depends on your diagnosis, your history, your current stability, your medication, and your individual circumstances.

What matters most is that you make an informed decision with accurate information and appropriate support. You're not being selfish by considering your mental health. You're recognizing that your wellbeing is inseparable from your baby's wellbeing.

Some women will safely discontinue medication before or during pregnancy. Others will continue treatment throughout pregnancy and breastfeeding. Both can be the right choice depending on the situation. What's not okay is making decisions based on fear, outdated information, or pressure from providers who aren't specialized in perinatal psychiatry.

Trust yourself to weigh the evidence and make the choice that protects both you and your baby. That might mean staying on medication. It might mean switching to a different medication with more safety data. It might mean carefully tapering off with close monitoring. Whatever you decide, make sure it's a decision you're making with full information and appropriate support.

Take the Next Step: Get the Support You Deserve

If you're struggling with questions about psychiatric medication safety during pregnancy or breastfeeding, you don't have to figure this out alone. Whether you're currently taking medication and just learned you're pregnant, planning a pregnancy and wondering about your options, or experiencing symptoms postpartum and unsure whether you can take medication while breastfeeding, specialized support is available.

Reach out to a perinatal psychiatrist or a maternal mental health program in your area. If your current provider isn't comfortable managing psychiatric medication during pregnancy, ask for a referral to someone with specific expertise in perinatal mental health. Your mental health during pregnancy and postpartum isn't a luxury. It's essential healthcare that you and your baby both deserve.

Don't wait until you're in crisis. The best time to have these conversations is now, whether you're planning pregnancy, newly pregnant, or already postpartum. With the right information and the right support, you can make a decision you feel confident about, one that honors both your mental health and your baby's wellbeing.

Ready to launch your behavioral health treatment center?

Join our network of entrepreneurs to make an impact